欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5271/001
药品名称Sitagliptine Sandoz 25 mg, filmomhulde tabletten
活性成分
    • SITAGLIPTIN hydrochloride 25.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Veluwezoom 22, 1327 AH Almere Nederland
参考成员国 - 产品名称Netherlands (NL)
Sitagliptine Sandoz 25 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
      Sitagliptin Sandoz 25 mg plėvele dengtos tabletės
    • Estonia (EE)
    • Hungary (HU)
      Sitagliptin 1 A Pharma 25 mg filmtabletta
    • Malta (MT)
      Sitagliptin PharOS 25 mg film-coated tablets
    • Belgium (BE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
许可日期2022/02/09
最近更新日期2023/09/26
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase